Socioeconomic Factors Linked to Persistently Active Rheumatoid Arthritis
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 22, 2024 -- Socioeconomic factors and deprivation are associated with persistently active rheumatoid arthritis (pactiveRA), according to a study published online July 14 in RMD Open.
Maryam Adas, from the King's College London Faculty of Life Sciences & Medicine, and colleagues examined which biological and nonbiological factors are associated with pactiveRA or persistently low RA (plowRA) (682 and 1,026 patients, respectively).
The researchers found that patients with pactiveRA were younger than those with plowRA (58 versus 62 years), and more were women (69 versus 59 percent). In patient-reported outcomes at baseline and anxiety and depression screens, pactiveRA was associated with worse scores. Overall, clear social patterning was seen in pactiveRA, with age-by-gender interaction. After controlling for disease severity markers, independent associations were seen for age, gender, social deprivation, and previous or current smoking with pactiveRA. Associations with pactiveRA were also seen for depression, lung disease, gastric ulcers, and baseline corticosteroid use.
"Identifying 'adverse' socioeconomic factors that could drive persistently active disease following diagnosis can help risk-stratify patients and tailor interventions according to individual characteristics and needs," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-23 01:15
Read more
- Bystanders More Readily Perform CPR If 911 Operator Instructs
- Teledermoscopy Accurate for Detecting Skin Cancers
- JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
- Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
- Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia
- Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions